The results appear to surpass those seen with Merck & Co Inc's pill molnupiravir, which was shown last month to halve the likelihood of dying or being hospitalized for Covid-19 patients also at high risk of serious illness.
from US News Headlines, Latest USA News, US news live on Times of India https://ift.tt/3wmEPx4
from US News Headlines, Latest USA News, US news live on Times of India https://ift.tt/3wmEPx4
Comments
Post a Comment